Stocks · Health care · Pharmaceutical Preparations

Harmony Biosciences Holdings, Inc.

HRMY Clue Score72

United States Fiscal year ends December CIK 0001802665 Results filed 4 Nov 2026

Add to watchlist

By person

7 insiders · 13 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Kumar Budur

Chief Medical Officer

—

$3.11M (7) scheduled

−$3.11M

13,115

0.0225%

$564.66K

+1,205%

Sandip Kapadia

Chief Financial Officer

—

$1.80M (4) scheduled

−$1.80M

24,521

0.0421%

$1.06M

−50.5%

Jeffrey M. Dayno

President, CEO

—

$1.04M (2) scheduled

−$1.04M

7,346

0.0126%

$316.28K

—

Adam H. Zaeske

Chief Commercial Officer

—

4,327

0.0074%

$186.30K

—

Andrew Serafin

Chief Strategy Officer

—

1,474

0.0025%

$63.46K

—

Valor IV Pharma Holdings, LLC entity

10% owner

—

0.0000%

$0.00

−100.0%

Jeffrey Dierks

Chief Commercial Officer

—

0.0000%

$0.00

—

Harmony Biosciences Holdings, Inc.

What the insiders did Mostly scheduled

By person